NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced third-quarter 2009 revenue of $540.8 million, down 6 percent or 4 percent constant dollar, compared with $573.7 million in the year-earlier period. Net loss for the 2009 third quarter was $9.3 million and diluted earnings per share was $(0.05) compared with net income of $75.9 million and EPS of $0.41 in the third quarter of 2008. After adjusting for a $106.3 million charge related to the previously announced restructuring and certain other items, net income on a non-GAAP basis for the third quarter of 2009 was $72.3 million compared with $79.4 million in the year-earlier period, and non-GAAP EPS was $0.40 compared with $0.43 in the 2008 third quarter (See Note c to the financial tables).
